LI
GMAB icon

LRI Investments’s Genmab GMAB Stock Holding History

LRI Investments’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2K Sell
372
-402
-52% -$10.7K ﹤0.01% 947
2026
Q1 		$20.8K Buy
774
+191
+33% +$5.72K ﹤0.01% 684
2025
Q4 		$18K Hold
583
– – ﹤0.01% 735
2025
Q3 		$17.9K Buy
583
+25
+4% +$609 ﹤0.01% 745
2025
Q2 		$11.5K Hold
558
– – ﹤0.01% 812
2025
Q1 		$10.9K Hold
558
– – ﹤0.01% 783
2024
Q4 		$11.6K Hold
558
– – ﹤0.01% 761
2024
Q3 		$11.8K Hold
558
– – ﹤0.01% 754
2024
Q2 		$14K Buy
558
+208
+59% +$5.9K ﹤0.01% 678
2024
Q1 		$10.5K Buy
+350
New +$10.3K ﹤0.01% 497

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

LRI Investments's GMAB Position: Q2 2026 in Review

LRI Investments reduced its Genmab (GMAB) stake by 52% in Q2 2026, selling an estimated $10.7K and leaving 372 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #947.

LRI Investments first reported a position in GMAB in Q1 2024 and has held it in 10 quarters since. The position peaked at $20.8K in Q1 2026. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • LRI Investments held 372 shares of Genmab worth $10.2K as of Q2 2026.
  • LRI Investments sold 402 Genmab shares in Q2 2026, an estimated $10.7K.
  • Genmab made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #947 holding.
  • LRI Investments first reported a position in Genmab in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Genmab position peaked at $20.8K in Q1 2026.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.